Heart Failure Clinical Trial

Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure

Summary

This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a cardiac catheterization laboratory (cath lab) and in a cardiac intensive care unit (ICU).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosed with NYHA class II-IV heart failure irrespective of ejection fraction
Patient is able to give consent

Exclusion Criteria:

Severe tricuspid regurgitation
Mechanical ventilation
Patient is pregnant
Inability to access either of the patient's upper arms.

Study is for people with:

Heart Failure

Estimated Enrollment:

43

Study ID:

NCT04928326

Recruitment Status:

Completed

Sponsor:

InCardia Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of California San Francisco
San Francisco California, 94143, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

43

Study ID:

NCT04928326

Recruitment Status:

Completed

Sponsor:


InCardia Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.